Ana Ruiz-Garcia

ResearcherID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Palliative Care

Plasmodium Falciparum

Hiv Infected Patients

Top Venues

Journal of pharmacokinetics and pharmacodynamics

Clinical and translational science

Clinical pharmacology and therapeutics

Cancer chemotherapy and pharmacology

Pfizer Inc

University of Valencia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Inc

United States

Sr. Director :: Clinical Pharmacology

Amgen Inc

United States

Scientist :: PDM

Sonus Pharmaceuticals

United States

Group Leader :: Pharmacology

Education History

University of Valencia

Spain

PHD :: Pharmaceutical Sciences

Washington State University

United States

PHD :: Pharmaceutical Science

Publications

Ana Ruiz-Garcia, Paul Baverel, Dean Bottino, Michael Dolton, Yan Feng, Ignacio González-García, Jaeyeon Kim, Seth Robey, Indrajeet Singh, David Turner, Shu-Pei Wu, Donghua Yin, Di Zhou, Hao Zhu, Peter Bonate
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development. Journal of pharmacokinetics and pharmacodynamics (2023)
Katherine Kay, Justin Goodwin, Hanna Ehrlich, Joyce Ou, Tracey Freeman, Kaicheng Wang, Fangyong Li, Martina Wade, Jonathan French, Liusheng Huang, Francesca Aweeka, Norah Mwebaza, Richard Kajubi, Matthew M Riggs, Ana Ruiz-Garcia, Sunil Parikh
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda. Clinical pharmacology and therapeutics (2022)
Rena J Eudy-Byrne, Nicole Zane, Susan C Adeniyi-Jones, Marc R Gastonguay, Ana Ruiz-Garcia, Gagan Kushal, Walter K Kraft
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome. Clinical and translational science 14 (6) (2021)
Ana Ruiz-Garcia, Anna Plotka, Melissa O'Gorman, Diane D Wang
Effect of food on the bioavailability of palbociclib. Cancer chemotherapy and pharmacology 79 (3) (2017)